ClearPoint Neuro, Inc. General form of registration statement for all companies including face-amount certificate companies

Income Taxes (Detail) - Components of Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2011	Dec. 31, 2010
Deferred tax assets (liabilities):
Property and equipment	$ (144,185)	$ (193,617)
Deferred revenue	1,517,024	2,503,984
Accrued expenses	1,138,800	1,518,400
Other	727,207	297,309
Net operating loss carryforwards	18,509,210	14,758,835
	21,748,056	18,884,911
Less valuation allowance	$ (21,748,056)	$ (18,884,911)

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.

Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.